Corticosteroids and risk of hospitalization for infection among cancer patients treated with programmed cell death receptor/ligand 1 (PD-1/PD-L1) inhibitors

被引：0
|
作者：
Sorup, Signe [1 ]
Darvalics, Bianka [1 ]
Russo, Leo [2 ]
Oksen, Dina [3 ]
Lamy, Francois-Xavier [3 ]
Verpillat, Patrice [3 ]
Sorensen, Henrik T. [1 ]
Cronin-Fenton, Deirdre [1 ]
机构：
[1] Aarhus Univ, Aarhus, Denmark
[2] Pfizer, Collegeville, PA USA
[3] Merck KGaA, Darmstadt, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
912
引用
收藏
页码：442 / 443
页数：2
相关论文
共 50 条
  • [1] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [2] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [3] Expression of Programmed Death Receptor 1 (PD-1) Gene and Its Ligand (PD-L1) in Patients with Laryngeal Cancer
    Kowalski, Andrzej
    Malinowska, Katarzyna
    Olszewski, Jurek
    Zielinska-Blizniewska, Hanna
    BIOMOLECULES, 2021, 11 (07)
  • [4] Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1)
    Wen, Biyan
    Zhao, Lin
    Wang, Yuchu
    Qiu, Chuangnan
    Xu, Zhimin
    Huang, Kunling
    Zhu, He
    Li, Zemin
    Li, Huangjin
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2020, 50 (03): : 252 - 259
  • [5] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [6] Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms
    Chen, Chi
    Pandey, Anita
    Kundra, Ajay
    Kodali, Sreenath
    Wong, Ching
    Cheung, Tony W.
    Gotlieb, Vladimir K.
    Joseph, Gardith
    Tribie, Sophia
    Wang, Jen-Chin
    BLOOD, 2018, 132
  • [7] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [8] Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) distribution in triple negative breast cancer (TNBC)
    Baker, T. M.
    Gatalica, Z.
    Goldstein, L. J.
    Obeid, E.
    CANCER RESEARCH, 2017, 77
  • [9] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
  • [10] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: a population-based study
    Lee, S.
    Zhou, J.
    Lakhani, I
    Yang, L.
    Liu, T.
    Zhang, Y.
    Xia, Y.
    Wong, W. T.
    Chan, E. W. Y.
    Wong, I. C. K.
    Tse, G.
    Zhang, Q.
    EUROPEAN HEART JOURNAL, 2022, 43
12345